hassan noorbazargan | Immunology | Best Researcher Award

Published on by Academic Excellence

Dr. hassan noorbazargan | Immunology | Best Researcher Award

Dr. hassan noorbazargan | Immunology | Carbon Technologies LLC | Oman 

Dr. Hassan Noorbazargan is a highly accomplished researcher specializing in biotechnology, immunology, and molecular diagnostics. He earned his Ph.D. in Medical Biotechnology from Shahid Beheshti University of Medical Sciences, Iran, where his doctoral work focused on the design and validation of advanced PCR assays for detecting HIV. His career reflects a strong combination of academic excellence and industrial expertise, spanning molecular diagnostics, vaccine production, recombinant protein development, and nanobiotechnology. Dr. Noorbazargan has held prominent roles at Carbon Technologies Co., ROJE Technologies, and the Pasteur Institute of Iran, where he contributed significantly to diagnostic assay development and vaccine quality control. His research contributions have led to impactful publications on nanocarriers, drug delivery, and novel therapeutic strategies for infectious diseases and cancer. Dedicated to advancing biotechnology and immunology, Dr. Noorbazargan continues to shape the scientific community with his innovative work, quality leadership, and pursuit of translational research.

Author Profiles

Orcid | Google Scholar

Education 

Dr. Hassan Noorbazargan pursued his Ph.D. in Biotechnology at Shahid Beheshti University of Medical Sciences, where he achieved a perfect GPA. His doctoral thesis focused on the design, development, and application of TaqMan real-time PCR for qualitative and quantitative detection of HIV, demonstrating his expertise in molecular diagnostics. Prior to this, he earned his M.Sc. in Microbiology from Islamic Azad University of Lahijan, where his thesis involved cloning and expression of the HCV core+1 protein in mammalian cells, highlighting his interest in virology and genetic engineering. He also completed his B.Sc. in Microbiology from the same university, where he developed a strong foundation in immunology, biochemistry, and cell biology. Through his academic journey, he undertook multiple research assistantships in microbiology and biotechnology labs, which helped refine his practical laboratory expertise. His educational achievements underline a consistent pursuit of excellence and research-driven learning.

Experience

Dr. Hassan Noorbazargan brings extensive experience in both academia and industry, specializing in diagnostics, vaccines, and nanobiotechnology. Currently serving as Senior Researcher & QC Head at Carbon Technologies Co., Muscat (2024–Present), he leads diagnostic kit validation for infectious diseases and ensures regulatory compliance. From 2019–2024, as Head of R&D at ROJE Technologies, he developed PCR assays for HIV, Hepatitis, and Influenza while managing technology transfer and GMP compliance. Earlier, he was a Senior R&D Specialist at Sinaclon, focusing on scaling molecular reagents and diagnostic kits. At the Pasteur Institute of Iran, he contributed as a Senior Scientist in BCG vaccine production and later as Scientific Advisor in vaccine development. His career also includes supervisory roles in clinical diagnostics and hands-on experience as a hospital lab technician. With a proven record in assay development, recombinant proteins, and nanocarriers, Dr. Noorbazargan continues to bridge research with translational healthcare solutions.

Awards and Honors

Throughout his career, Dr. Hassan Noorbazargan has earned recognition for his academic and research excellence in biotechnology and immunology. He successfully completed his Ph.D. with distinction at Shahid Beheshti University of Medical Sciences, where his groundbreaking work on HIV molecular detection positioned him as a leading scholar in molecular diagnostics. His innovative publications on nanocarriers, drug delivery systems, and novel therapeutic strategies for cancer and infectious diseases have been widely cited, reflecting their significant impact on the scientific community. He has also been acknowledged for his leadership in R&D roles, particularly in vaccine development and molecular assay validation, where his contributions directly influenced product innovation and clinical applications. In addition, Dr. Noorbazargan has participated in global training programs offered by WHO Academy, IAVI, Coursera, and edX, further strengthening his expertise. His ongoing pursuit of excellence and translational research has earned him recognition as a promising researcher in biotechnology and immunology.

Research Focus

Dr. Hassan Noorbazargan’s research is deeply rooted in immunology, nanobiotechnology, and molecular diagnostics. His focus lies in developing advanced diagnostic assays, nanocarrier-based drug delivery systems, and recombinant proteins for therapeutic and preventive medicine. A significant part of his work addresses infectious diseases such as HIV, Hepatitis, and COVID-19, where he has designed and validated cutting-edge PCR and ELISA-based assays for accurate detection. Beyond infectious diseases, his research explores innovative cancer therapies using niosomes, nanogels, and metal-organic frameworks for targeted and site-specific drug delivery. His publications highlight enhanced antibacterial, anticancer, and anti-metastatic strategies through engineered nanostructures, offering breakthroughs in precision medicine. He also contributes to vaccine research, optimizing immunogenicity assays and quality systems to improve vaccine safety and efficacy. By integrating molecular biology, immunology, and biotechnology, Dr. Noorbazargan’s research strengthens the bridge between laboratory innovation and clinical application, ultimately advancing global healthcare outcomes.

Publications

  • Narrative review on traditional medicine options for COVID-19 treatment.

  • Curcumin-loaded niosome nanocarriers for breast cancer therapy.

  • Ciprofloxacin-encapsulated niosomes for enhanced antibacterial activity.

  • Doxycycline-loaded niosomal formulation for prostate cancer treatment.

  • Niosome-loaded selenium nanoparticles for antibacterial and anticancer activities.

  • Folate-conjugated nanogels encapsulating oxaliplatin for colorectal cancer therapy.

  • Silver nanoparticles from Juniperus chinensis with anticancer properties.

  • Cefazolin-encapsulated UIO-66-NH2 nanoparticles against resistant S. aureus.

  • Folate-targeted curcumin-loaded niosomes for breast cancer treatment.

  • Biogenic AgNPs from Artemisia oliveriana for lung cancer therapy.

  • Engineered UIO-66 MOF delivering curcumin for breast cancer cells.

  • Super magnetic niosomal nanocarriers for breast cancer therapy.

Conclusion

Dr. Hassan Noorbazargan is a promising scientist whose research combines immunology, molecular diagnostics, and nanomedicine to address critical challenges in infectious diseases and cancer. With a balance of academic achievements, industrial expertise, and impactful publications, he stands as a strong candidate for global recognition in biomedical research.

 

Prof. Siddappa Byrareddy | Immunology and Microbiology | Best Researcher Award

Published on by Academic Excellence

Prof. Siddappa Byrareddy | Immunology and Microbiology | Best Researcher Award 🏆

professor. Siddappa Byrareddy, University of Nebraska Medical Center, United States🎓

Professional Profile

🌟Siddappa N. Byrareddy, Ph.D.

📘 Early Academic Pursuits

Dr. Siddappa N. Byrareddy’s journey into the world of virology and immunology began with a robust academic foundation in India. He completed his Bachelor of Science in Chemistry, Zoology, and Microbiology at Bangalore University in 1997. Following this, he earned a Master of Science in Biotechnology from the same institution in 1999. Dr. Byrareddy then pursued a Ph.D. in HIV Molecular Virology and Neuroscience at the Jawaharlal Nehru Center for Advanced and Scientific Research (JNCASR) & National Institute of Mental Health and Neurosciences (NIMHANS) in Bangalore, completing his doctorate in 2007.

🔬 Contributions and Research Focus

Dr. Byrareddy’s research is deeply rooted in the virology and immunology of infectious diseases, particularly focusing on emerging and re-emerging viruses such as HIV, Zika, SARS-CoV-2, and Mpox. His work emphasizes understanding HIV/SIV reservoirs within the CNS, including T and myeloid cells, and exploring neuroimmunology, infection, inflammation, and viral disease pathogenesis. His research portfolio encompasses viral immunology, epidemiology, the development of animal models for infectious and neurodegenerative diseases, host-virus interactions, Omics Pharmacology, and the pharmacokinetics/pharmacodynamics of antiviral drugs.

🌐 Impact and Influence

Dr. Byrareddy’s research has had a profound impact on the scientific community, especially his work on COVID-19, which has garnered widespread attention and has been referenced in the vaccine development strategies of Moderna and COVAXINTM. His mentorship has guided over 50 individuals, helping them secure admissions to esteemed institutions and independent positions in academia and industry. His collaborative efforts extend across a substantial network of researchers and clinicians at UNMC and internationally.

📈 Legacy and Future Contributions

Dr. Byrareddy’s legacy is marked by his relentless pursuit of scientific breakthroughs in the field of infectious diseases. His ongoing research and collaborative efforts continue to push the boundaries of our understanding of virology and immunology. As he advances in his career, Dr. Byrareddy remains committed to mentoring the next generation of scientists and contributing to significant discoveries that address critical questions in virology and immunology.

📖Publications : 

Dr. Wajid Hussain | Immunology and Microbiology | Research Excellence Award

Published on by Academic Excellence

Dr. Wajid Hussain | Immunology and Microbiology | Research Excellence Award 🏆

Doctor. Wajid Hussain, Huazhong University of Science and Technology, Wuhan, China 🎓

Professional Profile

🏆Wajid Hussain: A Journey of Scientific Innovation and Excellence 🌟

🎓Early Academic Pursuits

Wajid Hussain embarked on his academic journey with a Bachelor’s degree in Microbiology from Hazara University, Pakistan (2012-2016). His undergraduate research focused on Multi-Drug Resistant Pulmonary Tuberculosis in Northern Pakistan, conducted at the WHO Center for Pulmonary TB Control. His exemplary performance earned him the Best Student of the Session 2012-2016 award from the Study Aid Foundation of Pakistan. Building on this foundation, he pursued an M.Phil. in Microbiology at Huazhong University of Science and Technology (HUST), China (2017-2019), where he investigated the physiological functions of Vibrio cholerae conserved genes.

💼Professional Endeavors

Hussain’s professional journey is marked by diverse roles that reflect his expertise and commitment. He has served as a Research Assistant at the Biosensors and Biodiagnostics Laboratory at HUST, a Research Officer, and Research Associate at the Pakistan Council for Scientific & Industrial Research Laboratories Complex, and a Lecturer in Microbiology at Hazara University. His experience extends to roles in waste management, science education, and international student support. He currently works as a Ph.D. Scholar at the Advanced Biomaterial & Tissue Engineering Center, HUST, Wuhan, focusing on bacteriophage-based electrochemical detection of bacterial pathogens in food matrices.

🔬 Contributions and Research Focus

Hussain’s research primarily revolves around the innovative application of bacteriophages in electrochemical detection. His work aims to develop selective detection methods for bacterial pathogens such as Salmonella and E. coli in food, alongside fabricating biocompatible sensors and green electrodes. His research skills encompass a wide range of techniques, including molecular biology, analytical chemistry, and computational tools, showcasing his versatility and depth in the field.

🌍Impact and Influence 

Hussain’s work has significant implications for the fields of microbiology and biosensor technology. His research contributes to enhancing food safety through advanced detection methods and supports the development of eco-friendly sensor technologies. His roles in education and research have influenced the academic and scientific communities, particularly in the realm of microbial detection and biosensor innovation.

🔮Legacy and Future Contributions 

Looking ahead, Wajid Hussain is poised to make further strides in his field, with a focus on developing cutting-edge technologies for pathogen detection and sustainable biosensor solutions. His career reflects a commitment to addressing global challenges through scientific research and innovation, promising continued impact and advancement in microbiology and biosensor technology.

📖Publications :